Short answer · Medically reviewed summary · Last updated: 2026-04-06
Depression and anxiety are highly prevalent in individuals living with Scleroderma, affecting approximately 25% to 50% of patients due to the complex interplay of chronic pain, visible physical changes, and the unpredictable nature of the disease. Psychological Impact and Biochemical Links While Scleroderma is primarily an autoimmune connective tissue disease, the systemic inflammation associated with it may have secondary effects on mood regulation. However, the psychological burden is largely driven by the challenges of living with a chronic, multisystem condition.
2 people with Scleroderma have shared their first-person experience on this question at DiseaseMaps.
Depression and anxiety are highly prevalent in individuals living with Scleroderma, affecting approximately 25% to 50% of patients due to the complex interplay of chronic pain, visible physical changes, and the unpredictable nature of the disease.
While Scleroderma is primarily an autoimmune connective tissue disease, the systemic inflammation associated with it may have secondary effects on mood regulation. However, the psychological burden is largely driven by the challenges of living with a chronic, multisystem condition. Patients often face significant emotional distress related to body image changes—such as skin thickening or facial tightening—and the functional limitations caused by joint pain, fatigue, and Raynaud’s phenomenon.
It is vital to distinguish between normal grief over a diagnosis and clinical depression. Watch for persistent sadness, loss of interest in hobbies, significant changes in sleep or appetite, and social withdrawal. Because Scleroderma causes extreme fatigue, it can be difficult to differentiate between physical exhaustion and the lethargy of depression; if these feelings persist for more than two weeks, it is time to consult a professional.
Integrated care is essential for managing the mental health aspects of Scleroderma. Evidence-based therapies like Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) are highly effective in helping patients navigate the stresses of chronic illness. Medication, such as SSRIs, may be prescribed by your rheumatologist or a psychiatrist to manage symptoms. Furthermore, connecting with the Scleroderma community through support groups can reduce the profound isolation that often accompanies this rare disease.
If you feel overwhelmed, please reach out to your primary rheumatologist for a referral to a therapist who specializes in chronic illness. If you are experiencing a mental health emergency or suicidal thoughts, please call or text 988 in the US and Canada, or contact your local emergency services immediately.
Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult with your physician regarding your specific health needs.